ADJUVANT CAPITAL
Adjuvant Capital is a life sciences investment firm focused on global health. The company makes $10-$25 million investments in ambitious companies targeting opportunities in high burden and neglected disease. Adjuvant Capital was founded in 2012 by Charlie Petty, Glenn Rockman, and Kabeer Aziz and is based in New York.
ADJUVANT CAPITAL
Industry:
Financial Services Health Care Venture Capital
Founded:
2012-01-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon WordPress Apache Wordpress Plugins Euro Microsoft Exchange Online
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-02-16 | Memo Therapeutics | Adjuvant Capital investment in Series B - Memo Therapeutics | 23 M CHF |
| 2022-01-07 | Curevo | Adjuvant Capital investment in Series A - Curevo | 60 M USD |
| 2021-11-02 | Antiva Biosciences | Adjuvant Capital investment in Series D - Antiva Biosciences | 31 M USD |
| 2021-09-16 | 54gene | Adjuvant Capital investment in Series B - 54gene | 25 M USD |
| 2021-07-07 | VitriVax | Adjuvant Capital investment in Series A - VitriVax | N/A |
| 2021-05-27 | Pulmocide | Adjuvant Capital investment in Series C - Pulmocide | 92 M USD |
| 2021-02-24 | Yisheng Biopharma | Adjuvant Capital investment in Series B - Yisheng Biopharma | 130 M USD |
| 2021-02-17 | Excision BioTherapeutics | Adjuvant Capital investment in Venture Round - Excision BioTherapeutics | 60 M USD |
| 2021-02-03 | Frontier Nutrition | Adjuvant Capital investment in Series B - Frontier Nutrition | 6 M USD |
| 2021-02-02 | Excision BioTherapeutics | Adjuvant Capital investment in Series A - Excision BioTherapeutics | N/A |
More informations about "Adjuvant Capital"
About - Adjuvant Capital
Adjuvant Capital’s assets under management covered by the Impact Principles totals $300 million USD, for the period ending September 30, 2023. Our detailed BlueMark verification report can be found here. Assets under management …See details»
Adjuvant Capital - Crunchbase Investor Profile
Adjuvant Capital is a life sciences investment firm focused on global health. The company makes $10-$25 million investments in ambitious companies targeting opportunities in high burden and neglected disease. Adjuvant Capital was …See details»
Team - Adjuvant Capital
Adjuvant is a life sciences investment fund that backs ambitious companies developing drugs, …See details»
Adjuvant Capital - Investments, Portfolio & Company Exits
Adjuvant Capital 's most notable exits include AN2 Therapeutics, LakeShore Biopharma, and …See details»
Adjuvant Capital - Funding, Financials, Valuation & Investors
Adjuvant Capital has raised a total of $300M in a single venture fund, Adjuvant Capital Fund. …See details»
African genomics startup 54gene raises $15M led by …
Apr 14, 2020 New York-based Adjuvant Capital led the round 54gene will now deploy toward that goal. Founded in 2019 by Ene-Obong, the company is headquartered in Washington, DC with a biobank facility in Lagos ...See details»
Adjuvant Capital - Idealist
Adjuvant Capital (“Adjuvant”) is an ambitious life sciences investment fund established to …See details»
Adjuvant Capital - Devex
Learn more about Adjuvant Capital's jobs, projects, latest news, contact information and …See details»
Gates, Merck and Novartis-backed Adjuvant Capital raises $300M …
Feb 18, 2021 A major group of pharma and charitable groups have joined forces to raise a …See details»
Adjuvant Capital: Investment in Health Innovations
Apr 16, 2021 Adjuvant Capital’s investment fund could possibly produce life-changing …See details»
Adjuvant Capital Announces $300 Million Venture Fund Designed …
NEW YORK, Feb. 18, 2021 /PRNewswire/ -- Adjuvant Capital today announced an …See details»
Portfolio - Adjuvant Capital
Adjuvant is a life sciences investment fund that backs ambitious companies developing drugs, …See details»
Adjuvant Capital announces $300m venture fund to improve …
Glenn Rockman, Managing Partner, Adjuvant Capital: "Billions of people around the world live …See details»
Adjuvant rakes in $300m for debut public health fund
Feb 18, 2021 Adjuvant Capital has raised $300 million for its new venture fund focused on …See details»
Adjuvant Capital - Contacts, Employees, Board Members
Adjuvant Capital has 6 current employee profiles, including Principal and Co-Founder Charlie …See details»
Adjuvant Capital Announces $300 Million Venture Fund Designed …
Feb 18, 2021 Adjuvant Capital Announces $300 Million Venture Fund Designed to Improve …See details»
Glenn Rockman - Adjuvant Capital
Glenn is a finance professional with 20 years of experience in venture capital and investment …See details»
Bringing the VC approach to global health - Axios
Feb 24, 2021 Adjuvant Capital sees a social and business opportunity in that gap. Driving the …See details»
Paris dreams of becoming the capital of positive AI with the ...
1 day ago France will host 100 heads of state and some 600 business and NGO leaders from …See details»
News | Adjuvant Capital
2023-11-16 // Adjuvant Capital OPIM Disclosure Statement Go to Article. 2023-10-13 // Biden …See details»